B. Astroff

930 total citations
17 papers, 738 citations indexed

About

B. Astroff is a scholar working on Health, Toxicology and Mutagenesis, Genetics and Oncology. According to data from OpenAlex, B. Astroff has authored 17 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Health, Toxicology and Mutagenesis, 7 papers in Genetics and 3 papers in Oncology. Recurrent topics in B. Astroff's work include Toxic Organic Pollutants Impact (12 papers), Effects and risks of endocrine disrupting chemicals (9 papers) and Estrogen and related hormone effects (7 papers). B. Astroff is often cited by papers focused on Toxic Organic Pollutants Impact (12 papers), Effects and risks of endocrine disrupting chemicals (9 papers) and Estrogen and related hormone effects (7 papers). B. Astroff collaborates with scholars based in United States and Italy. B. Astroff's co-authors include Stephen Safe, R. Dickerson, Mark Anglin Harris, Lisa B. Biegel, Timothy R. Zacharewski, Marjorie Romkes, Tim Zacharewski, Craig Rowlands, Bruce F. Eldridge and S. Safe and has published in prestigious journals such as Chemosphere, Archives of Biochemistry and Biophysics and Biochemical Pharmacology.

In The Last Decade

B. Astroff

16 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Astroff United States 12 587 272 191 66 48 17 738
Andrew McDougal United States 13 378 0.6× 282 1.0× 149 0.8× 220 3.3× 41 0.9× 17 908
Jonathan T. Hamm United States 9 376 0.6× 63 0.2× 109 0.6× 117 1.8× 44 0.9× 12 607
Bradley E. Gillesby Canada 9 582 1.0× 272 1.0× 127 0.7× 133 2.0× 22 0.5× 9 815
V. Morrison United States 13 224 0.4× 85 0.3× 209 1.1× 169 2.6× 84 1.8× 20 520
Kelcey Walker United States 4 170 0.3× 121 0.4× 76 0.4× 103 1.6× 26 0.5× 4 354
C. H. Hurst United States 10 530 0.9× 56 0.2× 116 0.6× 150 2.3× 26 0.5× 10 698
Dilip D. Vakharia United States 14 343 0.6× 97 0.4× 157 0.8× 213 3.2× 78 1.6× 26 744
C. H. BASTOMSKY Canada 14 302 0.5× 80 0.3× 138 0.7× 103 1.6× 109 2.3× 30 736
Daniel C. Koch United States 8 298 0.5× 79 0.3× 86 0.5× 205 3.1× 50 1.0× 9 681
Jane M. Rogers United States 8 215 0.4× 88 0.3× 63 0.3× 82 1.2× 19 0.4× 10 357

Countries citing papers authored by B. Astroff

Since Specialization
Citations

This map shows the geographic impact of B. Astroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Astroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Astroff more than expected).

Fields of papers citing papers by B. Astroff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Astroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Astroff. The network helps show where B. Astroff may publish in the future.

Co-authorship network of co-authors of B. Astroff

This figure shows the co-authorship network connecting the top 25 collaborators of B. Astroff. A scholar is included among the top collaborators of B. Astroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Astroff. B. Astroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lednicky, John A., et al.. (2010). A nonlethal young domesticated ferret (Mustela putorius furo) model for studying pandemic influenza virus A/California/04/2009 (H1N1).. PubMed. 60(5). 364–8. 5 indexed citations
2.
Gasparini, Anna, Michela Tonetti, B. Astroff, et al.. (1992). Pharmacokinetics of Doxorubicin Loaded and Glutaraldehyde Treated Erythrocytes in Healthy and Lymphoma Bearing Dogs. PubMed. 326. 299–304. 4 indexed citations
3.
Piskorska-Pliszczynska, J., B. Astroff, Timothy R. Zacharewski, et al.. (1991). Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonists: Characterization of 6-[125I]methyl-8-iodo-1, 3-dichlorodibenzofuran-Ah receptor complexes. Archives of Biochemistry and Biophysics. 284(1). 193–200. 19 indexed citations
4.
Astroff, B., Bruce F. Eldridge, & Stephen Safe. (1991). Inhibition of the 17β-estradiol-induced and constitutive expression of the cellular protooncogene c-fos by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the female rat uterus. Toxicology Letters. 56(3). 305–315. 37 indexed citations
5.
Safe, Stephen, B. Astroff, Mark Anglin Harris, et al.. (1991). 2,3,7,8‐Tetrachlorodibenzo‐p‐dioxin (TCDD) and Related Compounds as Antioestrogens: Characterization and Mechanism of Action. Pharmacology & Toxicology. 69(6). 400–409. 243 indexed citations
6.
Astroff, B. & Stephen Safe. (1991). 6-Alkyl-1,3,8-trichlorodibenzofurans as antiestrogens in female Sprague-Dawley rats. Toxicology. 69(2). 187–197. 13 indexed citations
7.
Tonetti, Michela, et al.. (1990). Construction and characterization of adriamycin‐loaded canine red blood cells as a potential slow delivery system. Biotechnology and Applied Biochemistry. 12(6). 621–629. 26 indexed citations
8.
Astroff, B. & Stephen Safe. (1990). 2,3,7,8-tetrachlorodibenzo-p-dioxin as an antiestrogen: Effect on rat uterine peroxidase activity. Biochemical Pharmacology. 39(3). 485–488. 75 indexed citations
9.
Astroff, B., Craig Rowlands, R. Dickerson, & Stephen Safe. (1990). 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibition of 17β-estradiol-induced increases in rat uterine epidermal growth factor receptor binding activity and gene expression. Molecular and Cellular Endocrinology. 72(3). 247–252. 67 indexed citations
10.
11.
Harris, Mark Anglin, et al.. (1989). Characterization of 6-methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-TCDD antagonist in male rats: induction of monooxygenases. Chemosphere. 19(1-6). 769–772. 1 indexed citations
12.
Harris, Mark Anglin, Tim Zacharewski, B. Astroff, & S. Safe. (1989). Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies.. Molecular Pharmacology. 35(5). 729–735. 46 indexed citations
13.
Bannister, Roy, D. Davis, Lisa B. Biegel, B. Astroff, & Stephen Safe. (1989). 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-TCDD antagonist in C57BL/6 mice. Chemosphere. 19(1-6). 949–953. 1 indexed citations
14.
Bannister, Roy, Lisa B. Biegel, D. Davis, B. Astroff, & Stephen Safe. (1989). 6-methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6 mice. Toxicology. 54(2). 139–150. 40 indexed citations
15.
Astroff, B., Marjorie Romkes, & Stephen Safe. (1989). Mechanism of action of 2,3,7,8-tcdd and 6-methyl-1,3,8-trichlorodibenzofuran (MCDF) as antiestrogens in the female rat. Chemosphere. 19(1-6). 785–788. 2 indexed citations
16.
17.
Astroff, B. & Stephen Safe. (1988). Comparative antiestrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8-trichlorodibenzofuran in the female rat. Toxicology and Applied Pharmacology. 95(3). 435–443. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew McDougal Breakdown of academic impact, for papers by Jonathan T. Hamm Breakdown of academic impact, for papers by Bradley E. Gillesby Breakdown of academic impact, for papers by V. Morrison Breakdown of academic impact, for papers by Kelcey Walker Breakdown of academic impact, for papers by C. H. Hurst Breakdown of academic impact, for papers by Dilip D. Vakharia Breakdown of academic impact, for papers by C. H. BASTOMSKY Breakdown of academic impact, for papers by Daniel C. Koch Breakdown of academic impact, for papers by Jane M. Rogers
Rankless by CCL
2026